Literature DB >> 10092633

Transient and steady-state kinetics of the oxidation of substituted benzoic acid hydrazides by myeloperoxidase.

U Burner1, C Obinger, M Paumann, P G Furtmüller, A J Kettle.   

Abstract

Myeloperoxidase is the most abundant protein in neutrophils and catalyzes the production of hypochlorous acid. This potent oxidant plays a central role in microbial killing and inflammatory tissue damage. 4-Aminobenzoic acid hydrazide (ABAH) is a mechanism-based inhibitor of myeloperoxidase that is oxidized to radical intermediates that cause enzyme inactivation. We have investigated the mechanism by which benzoic acid hydrazides (BAH) are oxidized by myeloperoxidase, and we have determined the features that enable them to inactivate the enzyme. BAHs readily reduced compound I of myeloperoxidase. The rate constants for these reactions ranged from 1 to 3 x 10(6) M-1 s-1 (15 degrees C, pH 7.0) and were relatively insensitive to the substituents on the aromatic ring. Rate constants for reduction of compound II varied between 6.5 x 10(5) M-1 s-1 for ABAH and 1.3 x 10(3) M-1 s-1 for 4-nitrobenzoic acid hydrazide (15 degrees C, pH 7.0). Reduction of both compound I and compound II by BAHs adhered to the Hammett rule, and there were significant correlations with Brown-Okamoto substituent constants. This indicates that the rates of these reactions were simply determined by the ease of oxidation of the substrates and that the incipient free radical carried a positive charge. ABAH was oxidized by myeloperoxidase without added hydrogen peroxide because it underwent auto-oxidation. Although BAHs generally reacted rapidly with compound II, they should be poor peroxidase substrates because the free radicals formed during peroxidation converted myeloperoxidase to compound III. We found that the reduction of ferric myeloperoxidase by BAH radicals was strongly influenced by Hansch's hydrophobicity constants. BAHs containing more hydrophilic substituents were more effective at converting the enzyme to compound III. This implies that BAH radicals must hydrogen bond to residues in the distal heme pocket before they can reduce the ferric enzyme. Inactivation of myeloperoxidase by BAHs was related to how readily they were oxidized, but there was no correlation with their rate constants for reduction of compounds I or II. We propose that BAHs destroy the heme prosthetic groups of the enzyme by reducing a ferrous myeloperoxidase-hydrogen peroxide complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092633     DOI: 10.1074/jbc.274.14.9494

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Authors:  Anna-Karin Tidén; Tove Sjögren; Mats Svensson; Alexandra Bernlind; Revathy Senthilmohan; Francoise Auchère; Henrietta Norman; Per-Olof Markgren; Susanne Gustavsson; Staffan Schmidt; Stefan Lundquist; Louisa V Forbes; Nicholas J Magon; Louise N Paton; Guy N L Jameson; Håkan Eriksson; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Inhibition of Myeloperoxidase.

Authors:  Jala Soubhye; Paul G Furtmüller; Francois Dufrasne; Christian Obinger
Journal:  Handb Exp Pharmacol       Date:  2021

3.  A joint experimental and theoretical investigation of kinetics and mechanistic study in a synthesis reaction between triphenylphosphine and dialkyl acetylenedicarboxylates in the presence of benzhydrazide.

Authors:  Mohammad Amin Kazemian; Sayyed Mostafa Habibi-Khorassani; Ali Ebrahimi; Malek Taher Maghsoodlou; Peyman Mohammadzadeh Jahani; Mahbobeh Ghahramaninezhad
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

4.  Formation of reactive sulfite-derived free radicals by the activation of human neutrophils: an ESR study.

Authors:  Kalina Ranguelova; Annette B Rice; Abdelahad Khajo; Mathilde Triquigneaux; Stavros Garantziotis; Richard S Magliozzo; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2012-02-02       Impact factor: 7.376

5.  Mechanism of horseradish peroxidase inactivation by benzhydrazide: a critical evaluation of arylhydrazides as peroxidase inhibitors.

Authors:  Susan M Aitken; Marc Ouellet; M David Percival; Ann M English
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 6.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

7.  Production of reactive oxygen intermediates (O(2)(.-), H(2)O(2), and (.)OH) by maize roots and their role in wall loosening and elongation growth.

Authors:  Anja Liszkay; Esther van der Zalm; Peter Schopfer
Journal:  Plant Physiol       Date:  2004-10-01       Impact factor: 8.340

8.  Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood-brain barrier integrity and ameliorates disease severity.

Authors:  Hao Zhang; Avijit Ray; Nichole M Miller; Danielle Hartwig; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  J Neurochem       Date:  2015-11-30       Impact factor: 5.372

9.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

10.  Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors.

Authors:  Daniela Schuster; Martina Zederbauer; Thierry Langer; Andreas Kubin; Paul G Furtmüller
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.